The closing price of Teladoc Health Inc. (NYSE: TDOC) was 29.45 for the day, down -2.26% from the previous closing price of $30.13. In other words, the price has decreased by $-0.68 from its previous closing price. On the day, 3252578 shares were traded. TDOC reached its highest trading level at $30.20 during the session, while it also had its lowest trading level at $29.35.
Our analysis of TDOC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.72. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
On September 07, 2022, Truist started tracking the stock assigning a Hold rating and target price of $35.
Guggenheim Downgraded its Neutral to Sell on August 17, 2022, while the target price for the stock was maintained at $25.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 19 when Trencher Daniel sold 1,000 shares for $30.18 per share. The transaction valued at 30,180 led to the insider holds 25,408 shares of the business.
Geshuri Arnnon sold 4,098 shares of TDOC for $140,451 on Aug 26. The CHIEF PEOPLE OFFICER now owns 76,182 shares after completing the transaction at $34.27 per share. On Aug 17, another insider, Trencher Daniel, who serves as the SVP CORPORATE STRATEGY of the company, sold 1,000 shares for $37.50 each. As a result, the insider received 37,500 and left with 26,408 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.23 while its Price-to-Book (P/B) ratio in mrq is 0.78.
Stock Price History:
Over the past 52 weeks, TDOC has reached a high of $156.82, while it has fallen to a 52-week low of $27.38. The 50-Day Moving Average of the stock is 35.86, while the 200-Day Moving Average is calculated to be 55.05.
TDOC traded an average of 5.11M shares per day over the past three months and 4.16M shares per day over the past ten days. A total of 161.38M shares are outstanding, with a floating share count of 159.73M. Insiders hold about 0.20% of the company’s shares, while institutions hold 86.40% stake in the company. Shares short for TDOC as of Jul 14, 2022 were 33.3M with a Short Ratio of 6.57, compared to 36.65M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 20.66% and a Short% of Float of 23.57%.
The firm’s stock currently is rated by 18 analysts. On average, analysts expect EPS of $-0.55 for the current quarter, with a high estimate of $-0.34 and a low estimate of $-0.94, while EPS last year was $-0.53. The consensus estimate for the next quarter is $-0.46, with high estimates of $-0.24 and low estimates of $-0.9.
Analysts are recommending an EPS of between $-41.23 and $-44.16 for the fiscal current year, implying an average EPS of $-42.89. EPS for the following year is $-1.59, with 20 analysts recommending between $-0.64 and $-3.16.
A total of 26 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.46B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.41B. In the same quarter a year ago, actual revenue was $2.03B, up 18.70% from the average estimate. Based on 26 analysts’ estimates, the company’s revenue will be $2.86B in the next fiscal year. The high estimate is $3.17B and the low estimate is $2.65B. The average revenue growth estimate for next year is up 18.50% from the average revenue estimate for this year.